R. Mehani, A. Shukla, V. K. Yadav, and R. Sahu, “Evolocumab: rising momentum as novel antidyslipidemic drug”, Int J Basic Clin Pharmacol, vol. 6, no. 7, pp. 1538–1544, Jun. 2017.